FEBO Overview

MongoDB's Strong Performance: MongoDB, Inc. shares surged 31% in pre-market trading after reporting better-than-expected second-quarter results and raising its fiscal 2026 adjusted EPS guidance to between $3.64 and $3.73.

Other Gainers: Notable pre-market gainers included NovaBay Pharmaceuticals (up 66.7% due to a special cash dividend), Bollinger Innovations (up 32.1%), and BioXcel Therapeutics (up 19.5% after announcing Phase 3 data).

Pre-Market Losers: Stocks that declined in pre-market trading included Fenbo Holdings (down 16.8%), SCWorx Corp (down 15.2%), and Beneficient (down 14.3%).

Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting significant movements both upward and downward.

Financial Performance Overview: Fenbo Holdings Limited reported a 14.2% increase in revenues to HK$66.9 million for the first half of fiscal year 2024, but experienced a net loss of HK$1.9 million compared to a net income of HK$0.2 million in the same period last year, primarily due to rising administrative expenses.

Market Challenges and Future Outlook: The company is navigating market uncertainties influenced by geopolitical conflicts and inflation, while focusing on cost reduction, efficiency improvements, and expanding its customer base to enhance long-term profitability.